Challenges influencing the utilization of prostate brachytherapy in the United States
- 22 September 2020
- journal article
- letter
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 154, 123-124
- https://doi.org/10.1016/j.radonc.2020.09.025
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- ‘Dr Google’: trends in online interest in prostate cancer screening, diagnosis and treatmentBJU International, 2019
- Brachytherapy Training Survey of Radiation Oncology ResidentsInternational Journal of Radiation Oncology*Biology*Physics, 2018
- Stereotactic body radiation therapy (SBRT) for high-risk prostate cancer: Where are we now?Practical Radiation Oncology, 2018
- National trends in management of localized prostate cancer: A population based analysis 2004‐2013The Prostate, 2018
- Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate CancerInternational Journal of Radiation Oncology*Biology*Physics, 2017
- Brachytherapy boost for prostate cancer: Trends in care and survival outcomesBrachytherapy, 2017
- Prostate Brachytherapy Case Volumes by Academic and Nonacademic Practices: Implications for Future Residency TrainingInternational Journal of Radiation Oncology*Biology*Physics, 2016
- Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupBJU International, 2012
- Physician Visits Prior to Treatment for Clinically Localized Prostate CancerArchives of Internal Medicine, 2010
- Brachytherapy for Prostate Cancer: A Systematic ReviewAdvances in Urology, 2009